🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xueping Qu

First Affiliated Hospital of Xi'an Jiaotong University

ORCID: 0000-0002-4295-086X

Also affiliated with Corcept Therapeutics (United States), Xi'an Jiaotong University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Immune signatures to affect overall survival (OS) and response to bevacizumab (Bev) or cetuximab (Cet) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance).”.

Immune signatures to affect overall survival (OS) and response to bevacizumab (Bev) or cetuximab (Cet) in patients (pts) with metastatic colorectal cancer (mCRC) of CALGB/SWOG 80405 (Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.3515
N/A
0DataRank · unranked
0 citations

Akram Yazdani, Xueping Qu, Fang‐Shu Ou, Scott Van Buren, Omar Kabbarah +5 more

ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer

Nature Communications(2022)10.1038/s41467-022-33172-5
N/A
0DataRank · unranked
38 citations

Xueping Qu, Chu-Fang Lin, Ling‐Yuh Huw, Avinashnarayan Venkatanarayan, Ethan Sokol +14 more

Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3202
N/A
0DataRank · unranked
22 citations

Akram Yazdani, Naim Rashid, Xueping Qu, Fang‐Shu Ou, Scott Van Buren +7 more

Data from Tumor Immunogenomic Features Determine Outcomes in Patients with Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of Bevacizumab and Cetuximab

(2023)10.1158/1078-0432.c.6532436
N/A
0DataRank · unranked
0 citations

Akram Yazdani, Naim U. Rashid, Xueping Qu, Fang‐Shu Ou, Scott Van Buren +7 more

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

Communications Medicine(2025)10.1038/s43856-024-00728-z
N/A
0DataRank · unranked
6 citations

Heinz‐Josef Lenz, Gianluigi Pillonetto, Raúl Méndez-Giráldez, Hanna K. Sanoff, Reza Hadi +17 more

Gene signatures derived from transcriptomic-causal networks stratify colorectal cancer patients for effective targeted therapy

UNC Libraries(2025)10.17615/rbz3-7m15
N/A
0DataRank · unranked
0 citations

Scott Kopetz, Rashid, Naim U, Mark J. Ratain, Esmat Samiei, Federico Innocenti +18 more